FI944678L - 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia - Google Patents

3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia Download PDF

Info

Publication number
FI944678L
FI944678L FI944678A FI944678A FI944678L FI 944678 L FI944678 L FI 944678L FI 944678 A FI944678 A FI 944678A FI 944678 A FI944678 A FI 944678A FI 944678 L FI944678 L FI 944678L
Authority
FI
Finland
Prior art keywords
benzopyrans
dihydro
hydrazide derivatives
hydrazide
derivatives
Prior art date
Application number
FI944678A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944678A0 (fi
FI944678A7 (fi
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI944678A0 publication Critical patent/FI944678A0/fi
Publication of FI944678A7 publication Critical patent/FI944678A7/fi
Publication of FI944678L publication Critical patent/FI944678L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
FI944678A 1992-04-07 1993-03-12 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia FI944678L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400972 1992-04-07
PCT/US1993/002311 WO1993020059A1 (en) 1992-04-07 1993-03-12 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans

Publications (3)

Publication Number Publication Date
FI944678A0 FI944678A0 (fi) 1994-10-06
FI944678A7 FI944678A7 (fi) 1994-10-06
FI944678L true FI944678L (fi) 1994-10-06

Family

ID=8211648

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944678A FI944678L (fi) 1992-04-07 1993-03-12 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia

Country Status (19)

Country Link
EP (1) EP0635011B1 (enExample)
JP (1) JP3226174B2 (enExample)
KR (1) KR950700680A (enExample)
AT (1) ATE146466T1 (enExample)
AU (1) AU675784B2 (enExample)
CA (1) CA2132831C (enExample)
DE (1) DE69306770T2 (enExample)
DK (1) DK0635011T3 (enExample)
ES (1) ES2098730T3 (enExample)
FI (1) FI944678L (enExample)
GR (1) GR3022122T3 (enExample)
HU (1) HU215912B (enExample)
IL (1) IL105319A (enExample)
MX (1) MX9301979A (enExample)
NO (1) NO943760L (enExample)
NZ (1) NZ251174A (enExample)
TW (1) TW278076B (enExample)
WO (1) WO1993020059A1 (enExample)
ZA (1) ZA932414B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5510373A (en) * 1992-04-06 1996-04-23 Merrell Pharmaceuticals Inc. Cardioprotective agents
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010505A1 (de) * 1980-03-19 1981-10-01 Basf Ag, 6700 Ludwigshafen Chromanderivate, verfahren zu ihrer herstellung, ihre verwendung als stabilisatoren von organischen materialien sowie diese stabilisatoren enthaltende organische materialien
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
EP0369083A1 (en) * 1988-11-14 1990-05-23 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
KR900016822A (ko) * 1990-04-20 1990-11-14 하라 레이노스께 슬라이드 프로젝터

Also Published As

Publication number Publication date
ATE146466T1 (de) 1997-01-15
GR3022122T3 (en) 1997-03-31
MX9301979A (es) 1993-11-01
CA2132831C (en) 1998-06-16
EP0635011A1 (en) 1995-01-25
HU215912B (hu) 1999-03-29
DE69306770D1 (de) 1997-01-30
NO943760D0 (no) 1994-10-06
DK0635011T3 (da) 1997-01-06
IL105319A0 (en) 1993-08-18
WO1993020059A1 (en) 1993-10-14
AU675784B2 (en) 1997-02-20
JP3226174B2 (ja) 2001-11-05
HUT68833A (en) 1995-08-28
JPH07505625A (ja) 1995-06-22
AU3807293A (en) 1993-11-08
CA2132831A1 (en) 1993-10-14
HU9402882D0 (en) 1995-01-30
ZA932414B (en) 1993-10-22
IL105319A (en) 1998-02-22
NZ251174A (en) 1996-01-26
NO943760L (no) 1994-12-06
FI944678A0 (fi) 1994-10-06
KR950700680A (ko) 1995-02-20
ES2098730T3 (es) 1997-05-01
TW278076B (enExample) 1996-06-11
EP0635011B1 (en) 1996-12-18
DE69306770T2 (de) 1997-06-12
FI944678A7 (fi) 1994-10-06

Similar Documents

Publication Publication Date Title
FI930208L (fi) Kinazolinderivat
FI935431A7 (fi) Kiantsoliinijohdannaisia
FI980341L (fi) 2-oksi-indolijohdannaisia
ATA75293A (de) Indolderivate
FI933037A7 (fi) Tiazolylvinylfenylderivat
FI941423A7 (fi) 17beta-substituoidut 4-atsa-5alfa-androstan-3-onijohdannaiset
DE69330497D1 (de) Chinazolin-derivate
FI20010214A7 (fi) Asyyliaminoindolijohdannaisia
DE69329894D1 (de) Arylamidderivate
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI20002460L (fi) 4-difenyylimetyylipiperidiinijohdannaisia
FI933151L (fi) 5,10 metylentetrahydrofolsyre-cyklodextrin-inneslutningsfoereningar
FI930475A7 (fi) Oksiimijohdannaisia
NO932842L (no) 1,4-benzodioksanderivater
TR28264A (tr) 2-alkoksi-2-imidazolin-5-one'larin fungisidal türevleri.
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
NO952288D0 (no) Benzazepinon-derivater
DE69313890D1 (de) 5-Aminoflavon-Derivate
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI934928A7 (fi) Foerfarande foer framstaellning av 3,7-dialkylxantiner fraon 3-alkylxantiner
MX9204370A (es) Derivados de pirazol.
FI895977A7 (fi) 3,4-hydroksibentsoyloksipropanoliaminien esilääkeaine
LV11463A (lv) Aizvietotu 4,6-diamino-5-cianpirimidinu iegusanas panemiens
FI944678L (fi) 3,4-dihydro-2H-1-bentsopyraanien hydratsidijohdannaisia
FI930367L (fi) Puridinderivat